BioCatalystWatch
TRDAWorkspace / TRDA / OverviewCompany library
Entrada Therapeutics, Inc. logo

Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc. (TRDA)

Website

Price
Market cap
Next catalystExpected 2H 2026VX-670 — GALILEO and separate open-label extension · Phase 1/2 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

ENTR-601-44

DMD pre-mRNA exon 44

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

ENTR-601-45

DMD pre-mRNA exon 45

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ENTR-601-44

DMD pre-mRNA exon 44

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

ENTR-601-45

DMD pre-mRNA exon 45

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

ENTR-601-50

DMD pre-mRNA exon 50

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

USH2A pre-mRNA exon 13

ENTR-601-51

Upcoming / outlook

Partner / License out

History / paused

PreINDP1P2P3FilingApproved

Pathogenic CUG repeats in DMPK RNA

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TRDA PR & News

PR & News

TRDA SEC archive